Home›People›Gregory Oakes
Gregory Oakes

Gregory Oakes

Chief Executive Officer and Board Director at Slate Medicines.

Executive
Updated Nov 11, 2026·Latest SEC filing Mar 11, 2026·Suggest an edit

About Gregory Oakes

Gregory Oakes is a chief executive officer and board director at Slate Medicines.

Experience

This experience comes from Gregory Oakes's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gregory Oakes in the role, so the role may have started earlier or lasted longer.

Slate Medicines, Inc. Current
Chief Executive Officer and Board Director
2026 – Present · Boston, MA
Develops medicines to prevent migraines and other headache disorders.
Raven (RA Ventures)
Venture Partner
2025 – 2026
Landos Biopharma
President and CEO
2022 – 2024
Vifor Pharma
President North America
2020 – 2021
Celgene
Corporate Vice President & GM, Inflammation & Immunology
2017 – 2020
Novartis
Head of Biopharmaceuticals North America - Sandoz
2010 – 2017
Schering Pharmaceuticals
Vice President & General Manager, Czech Republic & Slovakia
1993 – 2010

Key Colleagues at Startups

The people Gregory Oakes works with at each company, as listed on that company's latest Form D.

Slate Medicines, Inc. · Form D, Mar 11, 2026
SP
Sara Pacheco
Executive officer
Tim Lohoff
Tim Lohoff
Principal, Forbion and director
CX
Cindy Xiong
Director
Neil Buckley
Neil Buckley
President and Chief Operating Officer, director
AL
Andrew Levin
Director

Sources

  1. SECSlate Medicines, Inc. Form D, filed Mar 11, 2026